An intervention to improve hydroxyurea adherence may improve quality of life in teens with SCD, according to an analysis of ...

Correctsequence's experimental gene-editing therapy CS-101 has been used to treat a person with SCD for the first time.

Patients with severe sickle cell disease experienced significant quality of life improvements after receiving exagamglogene autotemcel gene therapy.

Parents' childhood trauma may shape emergency care use patterns in their children with sickle cell disease, a study finds.